BIOCRYST PHARMACEUTICALS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $44.00K, a 388.89% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $33.00K, a 450.00% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $21.00K, a 250.00% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $9.00K, a 25.00% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2025 was $59.00K, a 73.53% increase from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2024 was $34.00K, a 90.06% decline from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2023 was $342.00K, a 80.00% increase from fiscal 2022.
- BIOCRYST PHARMACEUTICALS, INC. stock issued during period, value, issued for services for fiscal 2022 was $190.00K, a 216.67% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $44.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $33.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $59.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $21.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $9.00K 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $6.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $34.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $6.00K 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $12.00K 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $11.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $342.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $11.00K 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $206.00K 10-Q · filed 2024-11-05 | |
| 2022-12-31 | $190.00K 10-K · filed 2025-02-25 | |
| 2021-12-31 | $60.00K 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |